Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Humanized M-CSF specific monoclonal antibodies, kits, and uses thereof

Humanized M-CSF specific monoclonal antibodies, kits, and uses thereof

US Patent 11034759 · Granted Jun 15, 2021

Estimated economic value: $111,993,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Manufacturing method of electronic device2025
Integrated rapid treatment system for nuclear medical radioactive wastewater and2024
Chimeric antigen receptors targeting Fc receptor-like 5 and uses thereof2024
Manufacturing method of electronic device2024
Concrete interface agent2024
Antibody agents specific for human CD19 and uses thereof2024
Antibody/T-cell receptor chimeric constructs and uses thereof2024
Nucleic acid molecules encoding chimeric antigen receptors targeting G-protein c2024
Method, device, electronic equipment and medium for analyzing disaster preventio2024
Chimeric antigen receptors targeting G-protein coupled receptor and uses thereof2023
Antibodies targeting B-cell maturation antigen and methods of use2023
Detecting truncation and overlap defects on webpage2023